Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers

INTRODUCTION: Etrolizumab is a novel, dual-action anti-β7 integrin antibody studied in phase 3 trials in patients with inflammatory bowel disease. An autoinjector (AI) is being developed in parallel to complement the prefilled syringe with needle safety device (PFS-NSD) for subcutaneous (SC) adminis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Ther
Main Authors: Zhang, Wenhui, Tyrrell, Helen, Ding, Han Ting, Pulley, Jennifer, Boruvka, Audrey, Erickson, Rich, Abouhossein, Mariam, Ravanello, Renato, Tang, Meina Tao
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107163/
https://ncbi.nlm.nih.gov/pubmed/33778929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01661-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados